Axiora Medical
Axiora Medical
Engineered for durability, biocompatibility, and optimal surgical precision in Indian clinical theaters.
India is experiencing an unprecedented surge in demand for joint reconstruction systems. Driven by an aging demographic, a rising incidence of osteoarthritis, and expanding accessibility via state-supported healthcare schemes like Ayushman Bharat (PM-JAY), the market for Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA) is scaling at an annual growth rate of over 12%.
However, the Indian healthcare market presents a unique regulatory and commercial challenge. With price ceilings regulated under the National Pharmaceutical Pricing Authority (NPPA), hospitals, surgical units, and local distributors must balance clinical efficacy with strict cost containment. Sub-standard implants fail to provide the required wear-resistance and joint kinematics, while premium Western imports often carry cost structures that outpace reimbursement budgets.
Supporting global implant brands and municipal hospital distributors with integrated, high-precision orthopedic production lines.
A comparative overview of raw material standards, surface finish technologies, and quality control systems essential for modern arthroplasty success.
Indian hospitals demand materials that exhibit zero degradation. We utilize medical-grade titanium alloys (Ti6Al4V ELI conforming to ASTM F136) and high-nitrogen forged stainless steels. Our CoCrMo alloy meets ASTM F75 for superior articular wear-resistance.
Minimizing wear debris is paramount to preventing osteolysis. Our ultra-high-molecular-weight polyethylene (UHMWPE) and cross-linked polyethylene (XLPE) components are treated under vacuum to avoid oxidation and maintain physical integrity over decades.
Navigating CDSCO requirements for import registration (Form MD-15) demands precise technical documentation, including raw material tracing, sterilization validation (Gamma/EO), and mechanical wear testing datasets.
Axiora Medical Technology (China) Co., Ltd. stands at the forefront of orthopedic implant fabrication, leveraging 15 years of metallurgical and surgical design expertise. Our manufacturing facilities are equipped with 5-axis CNC machining centers, automated polishing stations, and advanced anodizing lines to guarantee dimensional tolerances within the micron range.
| Item / Parameter | Details & Compliance Standards |
|---|---|
| Company Name & Brand | Axiora Medical Technology (China) Co., Ltd. (Brand: Axiora) |
| Manufacturing Facilities | 18,600 m² footprint with automated CNC production lines and ISO Class 5 cleanrooms |
| Established Year & Experience | Established in 2017; 15 years of industry experience, 8 years of export history |
| Quality Control Staff & Protocol | 48 Quality Specialists conducting 100% finished product inspection & raw material analysis |
| Key Test Infrastructures | Coordinate Measuring Machine (CMM), Tensile Strength Testing, Rockwell Hardness, Surface Profilometry |
| Annual R&D Output | 126 new implants and custom instrument sets released in the previous calendar year |
| Regulatory Certificates | CE, ISO 13485, Class III Medical Device Product Registrations |
| Indian Local Services | Complete CDSCO documentation package provision, customized packaging, and private label OEM |
The evolution of orthopedic implants focuses on promoting stable biological fixation and reducing revision arthroplasty frequency.
To maximize early osteointegration, our titanium stems and acetabular cups feature a dual-layer coating structure. First, a plasma-sprayed rough titanium substrate promotes mechanical interlocking with the host bone. Second, a thin layer of highly crystalline Hydroxyapatite (HA) acts as a bio-conductive scaffold, accelerating bone inward growth. This significantly reduces the rate of aseptic loosening in cementless total hip replacements—a critical benefit for active, younger patients in India.
Our dual-mobility hip prosthesis design addresses instability—the leading cause of early THA revision. By offering two points of articulation (a small femoral head rotating inside an unconstrained polyethylene liner, which in turn rotates inside a metal cup), surgeons can achieve an exceptional range of motion with a negligible dislocation rate. This technology is highly requested by Indian surgical centers dealing with complex dysplastic hip pathologies.
The friction couple is the heart of joint replacement life expectancy. We manufacture and supply multiple configuration couples to meet diverse clinical profiles:
Full-process traceablity from raw titanium billet to final sterile barrier packaging.
Distributing orthopedic implants in India involves highly regionalized logistics networks, intensive bidding procedures, and complex compliance frameworks. We offer tailored solutions to ease these operations:
Our regulatory compliance team works in lockstep with your chosen Indian Authorized Agent (IAA) to prepare the technical dossier. We provide raw material mill test certificates, biocompatibility assessment reports (ISO 10993), clinical evaluation evaluations, and sterilization validation packages. This ensures a fast approval path under the Central Drugs Standard Control Organisation (CDSCO).
Indian surgical environments range from urban quaternary hospitals to rural centers. Our implants are packed in an ISO Class 5 cleanroom using double-barrier DuPont Tyvek blisters. This ensures the sterile integrity of the orthopedic implant is preserved under challenging tropical transport and warehousing conditions.
To view modular femoral heads and specialized cementless stems, browse the direct specifications below:
Complete modular implants and surgery-specific toolkits optimized for Indian medical procurement.
Addressing compliance, technical configuration, and shipment operations for the Indian market.
Obtain certified high-durability joint reconstruction solutions tailored for the Indian regulatory and healthcare framework. Reduce procurement overheads while elevating surgical success rates.
Send Inquiry Now
